Prognostic Factors and Functionality in Metastatic Spinal Cord Compression: Cohort Study

Authors

  • Eduarda Martins de Faria Centro Universitário IBMR. Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0002-5255-625X
  • Bianca Paraiso de Araujo Centro Universitário IBMR. Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0003-0928-8381
  • Patricia Almeida Chelles Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0001-5687-0302
  • Alessandra Grasso Giglio Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0003-4431-2535
  • Erica Alves Nogueira Fabro Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0003-0959-7678
  • Luciana Velasco Bizzo Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0003-4175-8021
  • Anke Bergmann Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0002-1972-8777
  • Luiz Claudio Santos Thuler Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Universidade Federal do Estado do Rio de Janeiro (Unirio). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0003-2550-6537
  • Gustavo Telles da Silva Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0001-7606-2564

DOI:

https://doi.org/10.32635/2176-9745.RBC.2022v68n2.2160

Keywords:

spinal cord compression, spinal neoplasms, neoplasm metastasis, prognosis

Abstract

Introduction: Metastatic Spinal Cord Compression (MSCC) has great potential of irreversible loss of motor and sensory function, and it is considered an oncological emergency. Objective: Evaluate the prognosis of MSCC and the functionality of patients with solid tumors. Method: Cohort study was conducted in patients with cancer who developed MSCC between January 2017 and December 2018. Clinical and socio-demographic data were extracted from physical and electronic charts. Survival analysis was performed by the Kaplan-Meier method. Results: The study included 90 patients who were diagnosed with MSCC. At the time of MSCC diagnosis, 55.5% of patients were unable to walk. Patients with MSCC after lung cancer had 4.1-fold more odds of death (95% CI: 1.79-9.41; p=0.001), those with genitourinary tumors, 1.9-fold higher risk of death (95% CI: 1.06-3.45; p=0,02), and with other types of tumors, 3.1-fold higher risk of death (95% CI: 1.58-6.24; p=0.001) when compared with patients with MSCC after breast cancer. Conclusion: The clinical relevance of this study relies on the findings that the primary type of tumor is a predictive factor for overall survival of MSCC. More than half of the patients were unable to walk at the MSCC diagnosis.

Downloads

Download data is not yet available.

References

New PW, Cripps RA, Bonne Lee B. Global maps of non-traumatic spinal cord injury epidemiology: towards a living data repository. Spinal Cord. 2014;52(2):97-109. doi: https://doi.org/10.1038/sc.2012.165

New PW, Marshall R. International spinal cord injury data sets for non-traumatic spinal cord injury. Spinal Cord. 2014;52(2):123-32. doi: https://doi.org/10.1038/sc.2012.160

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: https://doi.org/10.3322/caac.21492

Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2019.

Silva GT, Bergmann A, Thuler LCS. Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer. Support Care Cancer. 2016;24(2):731-6. doi: https://doi.org/10.1007/s00520-015-2835-1

Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s-9s. doi: https://doi.org/10.1158/1078-0432.CCR-06-0931

von Moos R, Body JJ, Egerdie B, et al. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Support Care Cancer. 2016;24(3):1327-37. doi: https://doi.org/10.1007/s00520-015-2908-1

Di Martino A, Caldaria A, De vivo V, et al. Metastatic epidural spinal cord compression. Expert Rev Anticancer Ther. 2016;16(11):1189-98. doi: https://doi.org/10.1080/14737140.2016.1240038

Patnaik S, Turner J, Inaparthy P, et al. Metastatic spinal cord compression. Br J Hosp Med (Lond). 2020;81(4):1-10. doi: https://doi.org/10.12968/hmed.2019.0399

Lawton AJ, Lee KA, Cheville AL, et al. Assessment and management of patients with metastatic spinal cord compression: a multidisciplinary review. J Clin Oncol. 2019;37(1):61-71. doi: https://doi.org/10.1200/JCO.2018.78.1211

Loblaw DA, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the cancer care ontario practice Guidelines Initiative’s Neuro-Oncology Disease Site Group. J Clin Oncol. 2005;23(9):2028-37. doi: https://doi.org/10.1200/JCO.2005.00.067

Mak KS, Lee LK, Mak RH, et al. Incidence and treatment patterns in hospitalizations for malignant spinal cord compression in the United States, 1998-2006. Int J Radiat Oncol Biol Phys. 2011;80(3):824-31. doi: https://doi.org/10.1016/j.ijrobp.2010.03.022

Silva GT, Bergmann A, Thuler LCS. Impact of symptomatic metastatic spinal cord compression on survival of patients with non-small-cell lung cancer. World Neurosurg. 2017;108:698-704. doi: https://doi.org/10.1016/j.wneu.2017.09.079

Lak AM, Rahimi A, Abunimer AM, et al. Quantifying the impact of surgical decompression on quality of life and identification of factors associated with outcomes in patients with symptomatic metastatic spinal cord compression. J Neurosurg Spine. 2020;33(2):237-44. doi: https://doi.org/10.3171/2020.1.SPINE191326

Tancioni F, Navarria P, Lorenzetti MA, et al. Multimodal approach to the management of metastatic epidural spinal cord compression (MESCC) due to solid tumors. Int J Radiat Oncol Biol Phys. 2010;78(5):1467-73. doi: https://doi.org/10.1016/j.ijrobp.2009.09.038

Pessina F, Navarria P, Carta GA, et al. Long-term follow-up of patients with metastatic epidural spinal cord compression from solid tumors submitted for surgery followed by radiation therapy. World Neurosurg. 2018;115:e681-e7. doi: https://doi.org/10.1016/j.wneu.2018.04.136

Younsi A, Riemann L, Scherer M, et al. Impact of decompressive laminectomy on the functional outcome of patients with metastatic spinal cord compression and neurological impairment. Clin Exp Metastasis. 2020;37(2):377-90. doi: https://doi.org/10.1007/s10585-019-10016-z

Scivoletto G, Lapenna LM, Di Donna V, et al. Neoplastic myelopathies and traumatic spinal cord lesions: an Italian comparison of functional and neurological outcomes. Spinal Cord. 2011;49(7):799-805. doi: https://doi.org/10.1038/sc.2011.6

Gedde MH, Lilleberg HS, Aßmus J, et al. Traumatic vs non-traumatic spinal cord injury: a comparison of primary rehabilitation outcomes and complications during hospitalization. J Spinal Cord Med. 2019;42(6):695-701. doi: https://doi.org/10.1080/10790268.2019.1598698

Fortin CD, Voth J, Jaglal SB, et al. Inpatient rehabilitation outcomes in patients with malignant spinal cord compression compared to other non-traumatic spinal cord injury: a population based study. J Spinal Cord Med. 2015;38(6):754-64. doi: https://doi.org/10.1179/2045772314Y.0000000278

Lei M, Yu J, Yan S, et al. Clinical outcomes and risk factors in patients with cervical metastatic spinal cord compression after posterior decompressive and spinal stabilization surgery. Ther Clin Risk Manag. 2019;15:119-27. doi: https://doi.org/10.2147/TCRM.S184497

He S, Wei H, Ma Y, et al. Outcomes of metastatic spinal cord compression secondary to primary hepatocellular carcinoma with multidisciplinary treatments. Oncotarget. 2017;8(26):43439-49. doi: https://doi.org/10.18632/oncotarget.15708

Silva GT, Costa TGP, Bessa CM, et al. Predictors of overall survival in non-small-cell lung cancer patients with metastatic spinal cord compression treated with short-course radiotherapy. Eur J Cancer Care (Engl). 2021;30(4):e13427. doi: https://doi.org/10.1111/ecc.13427

Rades D, Panzner A, Janssen S, et al. Outcomes after radiotherapy alone for metastatic spinal cord compression in patients with oligo-metastatic breast cancer. Anticancer Res. 2018;38(12):6897-903. doi: https://doi.org/10.21873/anticanres.13066

Rades D, Weber A, Karstens JH, et al. Prognostic role of the number of involved extraspinal organs in patients with metastatic spinal cord compression. Clin Neurol Neurosurg. 2014;118:12-5. doi: https://doi.org/10.1016/j.clineuro.2013.12.007

Tabouret E, Gravis G, Cauvin C, et al. Long-term survivors after surgical management of metastatic spinal cord compression. Eur Spine J. 2015;24(1):209-15. doi: https://doi.org/10.1007/s00586-014-3676-1

Lun DX, Chen NW, Feng JT, et al. Visceral metastasis: a prognostic factor of survival in patients with spinal metastases. Orthopc Surg. 2020;12(2):552-60. doi: https://doi.org/10.1111/os.12657

Pitz MW, Musto G, Navaratnam S. Sex as an independent prognostic factor in a population-based non-small cell lung cancer cohort. Can Respir J. 2013;20(1):30-4. doi: https://doi.org/10.1155/2013/618691

Karimi D, Morgen SS, Fruergaard S, et al. Long-term survival after surgical treatment of spinal metastasis - the predictive role of sex. Anticancer Res. 2020;40(3):1475-9. doi: https://doi.org/10.21873/anticanres.14091

Feng JT, Yang XG, Wang F, et al. Prognostic discrepancy on overall survival between ambulatory and nonambulatory patients with metastatic spinal cord compression. World Neurosurg. 2019;121:e322-e32. doi: https://doi.org/10.1016/j.wneu.2018.09.102

Published

2022-06-21

How to Cite

1.
Faria EM de, Araujo BP de, Chelles PA, Giglio AG, Fabro EAN, Bizzo LV, Bergmann A, Thuler LCS, Silva GT da. Prognostic Factors and Functionality in Metastatic Spinal Cord Compression: Cohort Study. Rev. Bras. Cancerol. [Internet]. 2022 Jun. 21 [cited 2024 May 17];68(2):e-182160. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/2160

Issue

Section

ORIGINAL ARTICLE

Most read articles by the same author(s)

<< < 3 4 5 6 7 8